H.R. 985 · 116th Congress
Fair Access for Safe and Timely Generics Act of 2019
- Stage
- In committee
- Sponsor
- Peter Welch
- Introduced
- 2019-02-05
- Latest action
- 2019-02-05 · Introduced in House
Summary
Fair Access for Safe and Timely Generics Act of 2019 or the FAST Generics Act of 2019
This bill generally prohibits the license holder of a drug or biological product approved by the Food and Drug Administration from restricting availability of the drug or product for testing by a product developer seeking to develop a drug, generic drug, or biosimilar.